Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)
China · Delayed Price · Currency is CNY 22.12
+0.31 (1.42%)
At close: Oct 23, 2026
SHA:603207 Market Cap
SHA:603207 has a market cap or net worth of 3.55 billion as of October 23, 2026. It is the 14,055th most valuable company in the world and the 3,745th biggest in China. Its market cap has decreased by 32.18% in one year.
Market Cap
3.55B
Enterprise Value
2.89B
Revenue
553.96M
Global Rank
Country Rank
#3,745 China
PE Ratio
18.57
ChartMarket Cap Chart
Since August 26, 2024, SHA:603207's market cap has decreased from 5.33B to 3.55B, a decrease of -33.29%. That is a compound annual growth rate of -17.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 3.55B | -22.66% |
| Dec 31, 2025 | 4.60B | 2.24% |
| Dec 31, 2024 | 4.49B | -15.65% |
| Aug 26, 2024 | 5.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jinhe Biotechnology CO., LTD. | 3.75B |
| Shandong Wohua Pharmaceutical | 3.68B |
| Zhejiang Yatai Pharmaceutical | 3.64B |
| Zhejiang Starry Pharmaceutical | 3.56B |
| Shenzhen Neptunus Bioengineering | 3.55B |
| PKU HealthCare Corp.,Ltd. | 3.49B |
| ChengDu ShengNuo Biotec | 3.46B |
| Harbin Medisan Pharmaceutical | 3.44B |